Category: Subclinical thyroid status

Letter on diagnosis published on British Medical Journal website

by thyroidpatientsca, posted in Our advocacy, Subclinical thyroid status, Testing policy, UK

Today, the British Medical Journal's website published my "rapid response" letter: How can truly hypothyroid patients be accurately diagnosed within the enlarged subclinical category? Link to full text: https://www.bmj.com/content/365/bmj.l2006/rr-6 It is a response to the new guidelines for subclinical hypothyroidism: Bekkering, G. E., Agoritsas, T., Lytvyn, L., Heen, A. F., Feller, M., Moutzouri, E., … … Continue reading Letter on diagnosis published on British Medical Journal website

CBC opinion article draft on subclinical hypothyroidism and its therapy

by thyroidpatientsca, posted in Diagnosis, Our advocacy, Subclinical thyroid status

I just sent this opinion article draft to the CBC opinion editors by email. --- Dear CBC opinion editors, I would like to offer my opinion piece on this trending topic. First, about me, then the article draft: I am the main researcher and writer for the Canadian Thyroid Patients' Campaign, who launched a federal … Continue reading CBC opinion article draft on subclinical hypothyroidism and its therapy

Subclinical hypothyroidism guidelines delay (in)effective therapy

by thyroidpatientsca, posted in Diagnosis, Subclinical thyroid status, Therapy guidelines

This week, a BBC news article is circulating with the report that "Thyroid disease [is] being over-treated." (May 15, 2019). (1) More specifically, it reported that newly published guidelines claim that "almost all adults with mild or "subclinical" hypothyroidism will not benefit from hormone treatment." In response, thyroid-treated persons who suffer poorly optimized thyroid hormone … Continue reading Subclinical hypothyroidism guidelines delay (in)effective therapy

REVIEW: Ineffectiveness of L-T4 monotherapy in subclinical hypothyroidism

by thyroidpatientsca, posted in Research Reviews, Subclinical thyroid status, T4-monotherapy

A new study published October 2018 has reviewed prior research on levothyroxine monotherapy in cases of "subclinical hypothyroidism" and has found it to be ineffective in improving quality of life and thyroid-related symptoms in patients. Studies like these could logically be used to launch a staunch critique against the presumed effectiveness of normalizing TSH via … Continue reading REVIEW: Ineffectiveness of L-T4 monotherapy in subclinical hypothyroidism